Picture of Clover Health Investments logo

CLOV Clover Health Investments News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Clover Health Investments Corp expected to post a loss of 11 cents a share - Earnings Preview

* Clover Health Investments Corp  CLOV.OQ   CLOV.O  is
expected
to show a fall in quarterly revenue when it reports  results 
    * The Franklin Tennessee-based  company is expected to
report  a
42.3% decrease in revenue to $494.6 million from $856.82 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Clover Health
Investments
Corp is for a loss of 11 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Clover
Health
Investments Corp is $1.63​, above​ its last closing price
of $1.09. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.15       -0.15      -0.06     Beat    60.1
 Mar. 31 2023  -0.17       -0.18      -0.15     Beat    14.7
 Dec. 31 2022  -0.23       -0.26      -0.17     Beat    31.4​
 Sep. 30 2022  -0.25       -0.24      -0.16     Beat    33.1
 ​​Jun.        -0.21       -0.21      -0.22     Missed  -6.7
 30 2022                                                
 Mar. 31 2022  -0.28       -0.27      -0.19     Beat    30.5​
 Dec. 31 2021  -0.27       -0.26      -0.28     Missed  -7.9
 Sep. 30 2021  -0.24       -0.23      -0.08     Beat    65
 This summary was machine generated November 4 at 00:51 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Clover Health Investments

See all news